期刊文献+

右布洛芬缓释干混悬剂的处方前研究 被引量:1

Research on the preformulation of Dexibuprofen Sustained-Release Dry Suspensions
下载PDF
导出
摘要 目的为研究右布洛芬缓释干混悬剂,测定药物在不同介质中的溶解度,进行原料药的稳定性及原辅料相容性研究。方法测定药物在不同pH缓冲液(pH 1.2、pH 4.5、pH 5.0、pH 6.8和pH 7.4)、水以及乙醇中的溶解度,在高温(60℃)高湿(RH 92.5%)、光照(4500 Lx)条件下,分别于第5、10天对原料药进行有关物质测定。在高温(60℃)、高湿(RH 92.5%)、光照(4500 Lx)条件下,分别于第5、10天对原辅料混合物进行有关物质测定。结果在pH 1.2~7.4范围内,药物溶解度随pH值升高而升高,易溶于乙醇。原料药对光照稳定,在高温条件下有关物质增加明显,在高湿条件下轻微吸潮,但3种条件下有关物质均<0.3%。在高温、高湿、光照条件下,原辅料混合物的有关物质均<0.3%。结论右布洛芬的溶解度受pH值影响,原料药对热较敏感,但与所选择辅料无配伍禁忌。 Objective To determine the solubility of drug in different media,to evaluate the stability of raw material and drug/excipient interactions for the development of Dexibuproten Sustained-Release Dry Suspensions.Methods The sol- ubility of the drug was determined indifferent pH buffer solutions (pH 1.2,pH 4.5,pH 5.0,pH 6.8 and pH 7.4),water and ethanol.The related substances of raw material were analyzed at lhc 5th and lOth days after storage under high tempera- ture (60℃),high humidity(RH 92.5%) and strong light (4500 Lx).The drug-exeipient interactions were also studied at the 5th and 10th days under high temperature (60℃),high humidity (RH 92.5%) and strong light (4500 Lx).Results The solubility of drug increased as the pH of solution increased in the range fi'om pH 1.2 to pH 7.4.The drug was highly soluble in ethanol.The related substances of raw material slightly increased under high temperature and showed hygro- scopicity under high humidity.But the related substancesafler storage under three different conditions were all less than 0.3%.The related substances from drug-excipient interactions under three conditions were below 0.3%.Conclusion The drug solubility showed a pH dependent manner.The raw material was quite sensitive to high temperature.No drug-ex- eipientinteractions were observed between the drug and excipients.
出处 《中国当代医药》 2018年第1期16-18,共3页 China Modern Medicine
关键词 右布洛芬 缓释干混悬剂 溶解度 稳定性 原辅料相容性 Dexibuprofen Sustained-release dry suspension Solnbility Stability Drug-excipient interactions
  • 相关文献

参考文献15

二级参考文献64

  • 1赖红卫,包月娥.使用消炎痛栓降温后重测体温时间探讨[J].护理学报,2007,14(2):46-47. 被引量:7
  • 2中国药典委员会.中华人民共和国药典[s].2部.北京:化学工业出版社,2005. 被引量:1
  • 3Gabard B,Nirnberger G.Comparison of the bioavailability of dexibuprofen administered alone or as part of racemic ibuprofen [J].Eur J Clin Pharmacol,1995,48:505-511. 被引量:1
  • 4Singer F,Mayrhofer F,Klein G,et al.Evaluation of the efficacy and dose-response relationship of dexibuprofen (S(+)-ibuprofen) in patients with osteoarthritis of the hip and comparison with racemic ibuprofen using the WOMAC osteoarthritis index [J].Int J C 被引量:1
  • 5Geisslinger G,Stock KP,Bach GL,et al.Pharmacological differences between R(-)-and S(+)-ibuprofen [J].Agents Actions,1989,27(3-4):455-457. 被引量:1
  • 6Sochor J,Klimes J,Sedlacek J,et al.Determination of ibuprofen in erythrocytes and plasma by high performance liquid chromatography [J].J Pharm Biomed Anal,1995,13(7):899-903. 被引量:1
  • 7Corpetti G,Rosignoli MT,Dionisio P.Comparative bioavilability study of two oral formulation of ibuprofen [J].Arzenim-forschung,1998,48(4):392-395. 被引量:1
  • 8Roger C.Validation of chromatographic methods in biomedical analysis viewpoint and discussion [J].J Chromatogr B,1997,689:175-180. 被引量:1
  • 9Frihmat R,Cardot JM,Boucher M,et al.Bioinversion of ibuprofen enatiomers after administration in dogs:estimation of a novel index [J].Eur J Drug Metab Pharmacokinet,2000,25:205-211. 被引量:1
  • 10Aiba T,Tse MM,Lin ET,et al.Effect of dosage form on stereoisomeric inversion of ibuprofen in volunteers [J].Bio Pharm Bull,1999,22:616-622. 被引量:1

共引文献62

同被引文献9

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部